Documents
Application Sponsors
ANDA 201275 | MYLAN PHARMS INC | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
None (Tentative Approval) | 004 |
Application Products
001 | CAPSULE;ORAL | EQ 12.5MG BASE | 0 | SUNITINIB MALATE | SUNITINIB MALATE |
002 | CAPSULE;ORAL | EQ 25MG BASE | 0 | SUNITINIB MALATE | SUNITINIB MALATE |
003 | CAPSULE;ORAL | EQ 37.5MG BASE | 0 | SUNITINIB MALATE | SUNITINIB MALATE |
004 | CAPSULE;ORAL | EQ 50MG BASE | 0 | SUNITINIB MALATE | SUNITINIB MALATE |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | TA | 2016-03-08 | |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
MYLAN PHARMS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 201275
[companyName] => MYLAN PHARMS INC
[docInserts] => ["",""]
[products] => [{"drugName":"SUNITINIB MALATE","activeIngredients":"SUNITINIB MALATE","strength":"EQ 12.5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SUNITINIB MALATE","activeIngredients":"SUNITINIB MALATE","strength":"EQ 25MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SUNITINIB MALATE","activeIngredients":"SUNITINIB MALATE","strength":"EQ 37.5MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"SUNITINIB MALATE","activeIngredients":"SUNITINIB MALATE","strength":"EQ 50MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"03\/08\/2016","submission":"ORIG-1","supplementCategories":"Tentative Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/201275Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"03\/08\/2016","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/201275Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/201275Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2016-03-08
)
)